BioSpace News Archive

Pharm Country

Marinus Pharmaceuticals Sells Rare Pediatric Disease Priority Review Voucher for $110 Million

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $110 million.

July 14, 2022
·
5 min read
Pharm Country

Annovis Bio to Present at the Alzheimer’s Association International Conference

Maria Maccecchini, Ph.D., Founder, President, and CEO, will be participating on a panel discussing the Systems Biology of Alzheimer’s Disease moderated by Jeffrey Cummings , MD, ScD, and Krista Lanctôt, Ph.D.

July 14, 2022
·
4 min read
Business

InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic Advisor

InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the prevention of stroke, announced the appointment of endovascular pioneer Dr. Juan Parodi as a strategic advisor to the Company.

July 14, 2022
·
4 min read
Pasithea Therapeutics Awarded a Drug Development Research Grant

Pasithea Therapeutics Corp. today announced the availability of an AUD $1 million (U.S. $694,000) drug development research award following the Company’s acquisition of Alpha-5 integrin, LLC (“Alpha-5”).

July 14, 2022
·
4 min read
Business

Medlogix Announces that Mary Hartquist has Joined their Business Development Team!

Medlogix, a leading national medical claims management solutions provider, has announced that Mary Hartquist has joined the organization as a Sales Manager in the Northeast Region.

July 14, 2022
·
2 min read
Business

Lightsense Technology and Severn Safety Supply Announce Joint Efforts to Introduce a New Handheld Fentanyl and Methamphetamine Dual Drug Detector to Law Enforcement in the USA

Lightsense Technology and Severn Safety Supply today announced a strategic partnership to help bring the newly launched DrugDetect-F1 to markets in specific areas of North America, utilizing their unique skills and relationships.

July 14, 2022
·
3 min read
Non-steroidal Anti-inflammatory Drugs Market Size USD 31.45 Billion by 2030

The global non-steroidal anti-inflammatory drugs market was surpassed at USD 19,551.54 million in 2021 and is expected to hit around USD 31.45 billion by 2030, growing at a CAGR of 5.42% from 2022 to 2030.

July 14, 2022
·
8 min read
Orthokeratology Lens Market Size USD 1.12 billion by 2030

The global orthokeratology lens market size was estimated at around USD 611.6 million in 2021 and it is projected to hit around USD 1.12 billion by 2030, growing at a CAGR of 6.95% from 2022 to 2030.

July 14, 2022
·
8 min read
Lone Star Bio

Nanoscope Therapeutics Receives Spotlight in Breakthrough Technologies Award at OIS Retina Innovation Summit

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that the Company was chosen for Breakthrough Technologies Award at OIS Retina Innovation Summit in New York.

July 14, 2022
·
2 min read
Skin Excision Market Size to Surpass Around USD 59.3 Billion by 2030

According to Latest Study, the global skin excision market was valued at USD 27.8 billion in 2021 and it is predicted to surpass around USD 59.3 billion by 2030 with a CAGR of 8.78% from 2022 to 2030.

July 14, 2022
·
6 min read